CAS NO: | 593274-97-6 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
2mg | 电议 |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | IntegrinAntagonists 27 is a small molecule integrinαvβ3 antagonistwith binding affinity of 18 nM, as s novel anticancer agent. Target:Integrinin vitro:IntegrinAntagonists 27 is treated with a panel ofcancercell-lines (breastcancercell line MDA-MB-435, breastcancercell lines MCF-7, mouse fibroblast NIH3T3, ovariancancercell line HEY, lungcancercell line NCI-H1975) with all IC50 of >20 uM. | ||||||||||||||||
分子量 | 444.44 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C24H20N4O5 | ||||||||||||||||
CAS 号 | 593274-97-6 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : ≥ 100 mg/mL(225.00 mM) *"≥" means soluble, but saturation unknown. 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|